Look for:

Our offer for

BAYER AG


ISIN:
DE000BAY0017
WKN:
BAY001

2024/04/25 16:40:53
Price
26.945 EUR
Difference -0.31% (-0.09)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)26,496 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)26.89 EUR (1,700)
Ask (Ask size)26.895 EUR (600)
Open26.895 EUR
High27.50 EUR
Low26.87 EUR
Close (prev. day)27.03 EUR
VWAP27.20646 EUR
Volume (pcs)186,334
Trading volume5,068,440.51
Number of trades588
Last size600

Futures and Options

Related Futures53
Related Options-

PDF Downloads

Company report: BAYER AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/25 16:40:53
Price
26.945 EUR
Difference -0.31% (-0.09)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)26,496 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)26.89 EUR (1,700)
Ask (Ask size)26.895 EUR (600)
Open26.895 EUR
High27.50 EUR
Low26.87 EUR
Close (prev. day)27.03 EUR
VWAP27.20646 EUR
Volume (pcs)186,334
Trading volume5,068,440.51
Number of trades588
Last size600

Performance and Risk

6m1Y3Y
Perf (%)-34.68%-55.29%-50.59%
Perf (abs.)-14.35-33.42-27.68
Beta1.181.090.77
Volatility40.2832.7429.16
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)26.878 EUR (244,027)
Ø price 30 days | Ø volume 30 days (pcs.)27.018 EUR (320,088)
Ø price 100 days | Ø volume 100 days (pcs.)29.729 EUR (482,066)
Ø price 250 days | Ø volume 250 days (pcs.)40.846 EUR (335,571)
YTD High | date36.085 EUR (2024/01/08)
YTD Low | date24.985 EUR (2024/03/07)
52 Weeks High | date60.790 EUR (2023/04/26)
52 Weeks Low | date24.985 EUR (2024/03/07)

All listings for BAYER AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/04/2516:4026.935 EUR58.127,115
Vienna Stock Exchange2024/04/2511:4827.36 EUR0.002
Tradegate2024/04/2516:4026.945 EUR4.97574
Stuttgart2024/04/2516:3526.96 EUR0.21126
SIX Swiss Exchange2023/02/2117:3560.00 EUR0.001
SIX Swiss Exchange2024/02/2617:35190.00 CHF0.001
Munich2024/04/2515:1827.16 EUR0.034
London Stock Exchange European Trade Reporting2024/04/2509:0027.1025 EUR0.003
Hanover2024/04/2508:2627.09 EUR0.002
Hamburg2024/04/2516:2626.95 EUR0.015
Frankfurt2024/04/2515:5827.01 EUR0.1124
FINRA other OTC Issues2024/04/2515:5828.97 USD0.013
Euronext Milan MTF Trading After Hours2024/04/1818:4426.03 EUR0.036
Euronext Milan MTF Global Equity Market2024/04/2516:3326.985 EUR0.80137
Duesseldorf2024/04/2516:3126.99 EUR0.004
Budapest Stock Exchange2024/04/2317:2010,716.00 HUF1.471
Bucharest Stock Exchange2024/04/2411:48136.40 RON0.032
Berlin2024/04/2516:4026.935 EUR0.0011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=958&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAYER AG
- -
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen
Telefon: +49-214-30-1
Fax: +
E-mail: -

PDF Downloads

Company report: BAYER AGPDF Download

Company Profile

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and womenšs health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Members of Management Board

B. Chuck AndersonChairman of Managing Board
Heike PrinzMember of Executive Committee
Heiko SchipperMember of Executive Committee
Rodrigo SantosMember of Executive Committee
Stefan OelrichMember of Executive Committee
Wolfgang NicklMember of Executive Committee

Board of directors

Norbert WinkeljohannChairman of Supervisory Board
Barbara GansewendtMember of Supervisory Board
Ertharin CousinMember of Supervisory Board
Norbert W. BischofbergerMember of Supervisory Board
Otmar WiestlerMember of Supervisory Board
Paul AchleitnerMember of Supervisory Board
Simone Bagel-TrahMember of Supervisory Board
Alberto WeisserMember of Supervisory Board
Andrea SacherMember of Supervisory Board
André van BroichMember of Supervisory Board
Claudia SchadeMember of Supervisory Board
Colleen GogginsMember of Supervisory Board
Francesco GrioliMember of Supervisory Board
Frank LöllgenMember of Supervisory Board
Heike HausfeldMember of Supervisory Board
Heinz Georg WebersMember of Supervisory Board
Horst Heinz Paul BaierMember of Supervisory Board
Kimberly Marie Lein-MathisenMember of Supervisory Board
Michael WestmeierMember of Supervisory Board
Yasmin FahimiMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer